Solid Biosciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio12.9814.17
P/B Ratio1.160.980.500.933.78
Price/Tangible Book1.160.980.500.933.78
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-0.95%-0.57%-0.41%-0.42%-0.83%
Return on Assets (ROA)-0.46%-0.31%-0.24%-0.22%-0.39%
Return on Capital Employed (ROCE)-0.82%-0.69%-0.40%-0.35%-0.59%
Leverage & Solvency Ratios
Debt/Equity0.180.210.140.010.04
Liquidity Ratios
Current Ratio5.208.949.769.436.49
Quick Ratio4.928.529.498.816.32
Efficiency Ratios
Asset Turnover0.030.07
Yield & Distribution Ratios
Earnings Yield-0.78%-0.78%-0.82%-0.37%-0.18%
FCF Yield-0.63%-0.77%-0.96%-0.41%-0.12%
Buyback Yield-1.05%-1.34%-0.20%-1.06%-0.29%